Scientists have found that glucose plays a significant role in how the brain functions.

Published Date: 26 Apr 2023

Nearly a quarter of the body's sugar energy, or glucose, is consumed daily by the human brain, which also has a sweet tooth. Now, scientists from the Gladstone Institutes and UC San Francisco (UCSF) have provided fresh insight into how.

Read Full News

Latest News

GLP-1s Linked to Lower Mortality in Patients With Brain Mets

Among patients with cancer, brain metastases, and type 2 diabetes, GLP-1 use is associated with lower all-cause mortality, new data suggest.

Osteoarthritis Knee Pain Impairs Diabetes Glycemic Control

New research hints at a connection between knee pain and glycemic results, but more research is needed.

GLP-1s a Viable Option to Treat, Prevent SUDs?

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Inpatient Glucose Testing Triples Postpartum Screening

Giving an inpatient oral glucose tolerance test before delivery discharge for women with gestational diabetes tripled the completion rate compared to postpartum testing.

Structure's Obesity Pill Shows Up to 16.3% Weight Loss in Study

Structure Therapeutics said on Monday its pill helped patients lose up to 16.3% of their weight, strengthening ⁠its bid to challenge Eli Lilly and Novo Nordisk in the...

Upcoming Guidance to Address GLP Drugs in Type 1 Diabetes

Off-label adjunctive use requires careful dosing, dose adjustments of insulin and other medications, and close monitoring.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Latest News

Among patients with cancer, brain metastases, and type 2 diabetes, GLP-1 use is associated with lower all-cause mortality, new data suggest.

New research hints at a connection between knee pain and glycemic results, but more research is needed.

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Giving an inpatient oral glucose tolerance test before delivery discharge for women with gestational diabetes tripled the completion rate compared to postpartum testing.

Structure Therapeutics said on Monday its pill helped patients lose up to 16.3% of their weight, strengthening ⁠its bid to challenge Eli Lilly and Novo Nordisk in the...

Off-label adjunctive use requires careful dosing, dose adjustments of insulin and other medications, and close monitoring.

News All Time

India Warns Drugmakers Against Weight-Loss Drug Ads

India's drug regulator has warned pharmaceutical companies against direct or indirect advertising of weight-loss medicines, including obesity awareness campaigns that could...

Digital Microsteps Help GLP-1 Users Adopt Healthy Behaviors

Digitally delivered behavior-change prompts plus short videos can boost GLP-1 users’ expectations to adopt healthy lifestyle behaviors.

From Open Surgery to AI in Kidney Stone Care

Miniaturized percutaneous techniques, flexible ureteroscopy, and outpatient protocols have shortened hospital stays and improved recovery, reshaping quality-of-life outcomes for patients.

Early Introduction of Tirzepatide Yields T2D Benefits

Two-year data from Eli Lilly’s SURPASS-EARLY trial show reduced A1c, body weight, and cardiovascular risk factors.

West Virginia Can Ban Medicaid Coverage for Gender-affirming Surgery, US Court Rules

A U.S. appeals court on Tuesday upheld West Virginia's ban on Medicaid coverage for gender-affirming surgeries, the latest victory for Republican-led states seeking to curb...

Majority of Papillary Thyroid Cancer Cases Are Overdiagnosis

Study finds up to 94% of papillary thyroid cancers in the past three decades were overdiagnosed, with stable mortality rates, despite soaring detection rates.

Eli Lilly to Invest $3 Billion in China

Eli Lilly plans to invest $3 billion in China, which ⁠will help build production capacity for its experimental type-2 diabetes and obesity treatment orforglipron.

GLP-1s Effective for Migraine Management?

Real-world data suggest GLP-1 receptor agonists may reduce emergency care visits and the need for additional migraine treatments in adults with chronic migraine.

Parental Obesity Linked to Increased MASLD Risk in Offspring

Elevated prepregnancy BMI in either parent is linked to increased odds of offspring developing metabolic dysfunction-associated steatotic liver disease in early adulthood.

Bariatric Surgery Reduces Sleep Apnea Long Term

In adults with obesity, bariatric surgery is linked to a higher sleep apnea remission rate and fewer new cases of obstructive sleep apnea over 20 years than usual obesity care.

Predicting Early Weight Regain After Sleeve Gastrectomy

Lower preoperative BMI and suboptimal 12-month weight loss are linked to rapid weight regain within 2 years after sleeve gastrectomy.

Lindt Says Weight-loss Drugs Users Are Eating More Chocolate, Not Less

Chocolate sales are rising faster among U.S. users of GLP-1 weight-loss drugs ⁠than in the rest of the population, Swiss chocolatier Lindt & Spruengli said on Tuesday,...

Targeted Brain Tumour Drug Approved for NHS Scotland

Scotland has approved the targeted therapy vorasidenib for some low-grade brain tumours, while NICE in England continues to review its cost-effectiveness.

When Lab Reference Values May Mislead Clinicians

Laboratory reference ranges reflect methods, populations, and policies, and experienced clinicians interpret them in context rather than applying fixed cutoffs theoretically.

Novo and Hims to Sell Obesity Drugs Together as Feud Ends, Bloomberg News Reports

Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on ⁠Hims & Hers Health platform, bringing an end to a dispute between the ⁠two companies that escalated...

How Policy and New Drugs Reshaped Obesity Treatment

The 2013 declaration of obesity as a chronic disease and the 2021 approval of semaglutide are associated with increased use of antiobesity medications, while bariatric surgery rates remain stable.

Recommended News For You

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

Did U.S. Government Play a Role in Remote Tribe's Widespread Illness and Cancer?

Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

Recommended Articles For You

Anesthetic Techniques and Strategies in Cancer Surgery: Unveiling the Impact on Oncological Outcomes 

Unlocking the Secrets of Hemoglobin: Exploring the Wonders of Life-Sustaining Iron Compounds 

CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target 

Molecular & Genetic Oncology: Emerging Frontiers in 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

2.

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

3.

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.

4.

Medicaid expansion tied to smaller declines in early-stage cancer detection

5.

Using AI, one can find cancer risk factors.

1.

Unlocking the Potential of Cancer Antigen 19-9 for Early Detection

2.

The Basics of M.C.V Normal Range for Better Health Management

3.

Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management

4.

Understanding Epoetin and Its Role in Treating Chronic Kidney Disease 

5.

Understanding Pomalidomide: A promising drug for multiple myeloma treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

4.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot